Vyant Bio (VYNT)
OTHER OTC:VYNT
US Market

Vyant Bio (VYNT) Financial Statements

425 Followers

Vyant Bio Financial Overview

Vyant Bio's market cap is currently ―. The company's EPS TTM is $-2.282; its P/E ratio is -0.07; Vyant Bio is scheduled to report earnings on August 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 41.00K$ 152.00K$ 165.00K$ 303.00K$ -2.53M
Gross Profit$ -15.00K$ -105.00K$ -139.00K$ -83.00K$ -1.10M
EBIT$ -3.49M$ -3.68M$ -4.34M$ -4.40M$ -2.63M
EBITDA$ -3.29M$ -3.48M$ -4.13M$ -4.16M$ -2.63M
Net Income Common Stockholders$ -4.26M$ -3.46M$ -5.80M$ -9.16M$ -24.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.00M$ 9.39M$ 11.70M$ 16.44M$ 20.61M
Total Assets$ 15.21M$ 23.04M$ 26.81M$ 32.53M$ 37.64M
Total Debt$ 2.20M$ 2.33M$ 2.19M$ 2.25M$ 1.20M
Net Debt$ -7.80M$ -7.07M$ -9.51M$ -14.19M$ -19.41M
Total Liabilities$ 5.30M$ 9.20M$ 10.02M$ 10.16M$ 6.35M
Stockholders Equity$ 9.91M$ 13.84M$ 16.79M$ 22.37M$ 31.29M
Cash Flow-
Free Cash Flow$ -3.65M$ -2.50M$ -4.49M$ -4.00M$ -3.02M
Operating Cash Flow$ -3.64M$ -2.25M$ -4.16M$ -3.97M$ -3.00M
Investing Cash Flow$ 3.87M$ -251.00K$ -373.00K$ -60.00K$ -73.00K
Financing Cash Flow$ -38.00K$ 197.00K$ -202.00K$ -136.00K$ 481.00K
Currency in USD

Vyant Bio Earnings and Revenue History


Vyant Bio Debt to Assets


Vyant Bio Cash Flow


Vyant Bio Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis